• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Putative UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase LOC402377, Truncated

ACP19829

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP19829 Target Synonyms; Putative UDP-GlcNAc:betaGal beta-1, 3-N-acetylglucosaminyltransferase 5 pseudogene, 3-N-acetylglucosaminyltransferase LOC100288842; EC 2.4.1.-; Putative UDP-GlcNAc:betaGal beta-1, 3-N-acetylglucosaminyltransferase LOC402377; UDP-GlcNAc:betaGal beta-1
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDA8MXE2
Background Information
  • Uniprot Id

    A8MXE2

  • Target Species

    Human

  • Target Name

    B3GALT9

  • Target Full Name

    Beta-1,3-galactosyltransferase 9

  • Target Function

    Putative glycosyltransferase that could catalyze the transfer of galactose residues from UDP-alpha-D-galactose.

  • Target Subcellular Location

    Golgi apparatus membrane; Single-pass type II membrane protein.

  • Target Protein Families

    Glycosyltransferase 2 family

  • Target Synonyms

    ; Putative UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase LOC100288842; EC 2.4.1.-; Putative UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase LOC402377; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 pseudogene

Inquire Recombinant Human Putative UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase LOC402377, Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification